Mark Lee
Impact in
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases
- Parkinson's Disease Mechanisms and Treatments
- Vascular Malformations Diagnosis and Treatment
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
- Neurology 13
- Neurological disorders and treatments 3
- Vascular Malformations Diagnosis and Treatment 3
- Parkinson's Disease Mechanisms and Treatments 3
- Facial Nerve Paralysis Treatment and Research 3
- Co-authors
- Fred J. Epstein (7 shared papers)Ali R. Rezai (4 shared papers)Rick Abbott (3 shared papers)Richard Walker (1 shared paper)Nobu Morota (3 shared papers)David Zagzag (2 shared papers)Vedran Deletis (3 shared papers)Diana Freed (1 shared paper)
- Journals
- Neurosurgery (5 papers)Parkinsonism & Related Disorders (2 papers)Cancer Research and Treatment (1 paper)JAMA Network Open (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Mark Lee
43 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Neurology 372
- Molecular Medicine 93
- Genetics 146
- Applied Microbiology and Biotechnology 26
- Endocrinology 52
Countries citing papers authored by Mark Lee
This map shows the geographic impact of Mark Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lee more than expected).
Fields of papers citing papers by Mark Lee
This network shows the impact of papers produced by Mark Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lee. The network helps show where Mark Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 151 | |
| 2 | Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the US Hit paper breakdown → | 2022 | 105 |
| 3 | 2010 | 101 | |
| 4 | 1995 | 76 | |
| 5 | 1996 | 74 | |
| 6 | 1995 | 73 | |
| 7 | 1998 | 64 | |
| 8 | 2023 | 49 | |
| 9 | 2016 | 48 | |
| 10 | 1994 | 47 | |
| 11 | 2000 | 47 | |
| 12 | 1996 | 41 | |
| 13 | 2011 | 36 | |
| 14 | 2017 | 26 | |
| 15 | 2007 | 26 | |
| 16 | 2022 | 24 | |
| 17 | 2011 | 22 | |
| 18 | 2014 | 21 | |
| 19 | 1995 | 20 | |
| 20 | 2010 | 17 |
About Mark Lee
Mark Lee is a scholar working on Neurology, Otorhinolaryngology, Genetics, Speech and Hearing and Health, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Meningioma and schwannoma management (6 papers), Glioma Diagnosis and Treatment (5 papers), Dermatology and Skin Diseases (3 papers), Neurological disorders and treatments (3 papers), Vascular Malformations Diagnosis and Treatment (3 papers), Health disparities and outcomes (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Facial Nerve Paralysis Treatment and Research (3 papers). The work is most often cited by research in Neurology (372 citations), Molecular Medicine (93 citations), Genetics (146 citations), Applied Microbiology and Biotechnology (26 citations) and Endocrinology (52 citations). Mark Lee has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Fred J. Epstein, Ali R. Rezai, Rick Abbott, Richard Walker, Nobu Morota, David Zagzag, Vedran Deletis, Diana Freed, David J. Burn and Mary Vearncombe. Their work appears in journals such as Neurosurgery, Parkinsonism & Related Disorders, Cancer Research and Treatment, JAMA Network Open and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.